Experienced in Gallbladder Disease

Wei Z. Shen

No. 221 West Yanan Road, 
Shanghai, CN 
Experienced in Gallbladder Disease
No. 221 West Yanan Road, 
Shanghai, CN 
OverviewLocationsClinical Research

Overview

Wei Shen practices in Shanghai, China. Shen is rated as an Experienced expert by MediFind in the treatment of Gallbladder Disease. Their top areas of expertise are Obesity, Hallermann-Streiff Syndrome, Gallstones, Liver Transplant, and Endoscopy.

Their clinical research consists of co-authoring 414 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 6 articles in the study of Gallbladder Disease.

Locations

No. 221 West Yanan Road, Shanghai, 200040, China
Other Locations
No.1 Minde Road, Nanchang, 330006, China
No. 168 Changhai Road, Shanghai, 200433, China
No. 1 Min De Road, Nanchang, 330006, China
176 Qingnian Road, Kunming, China
No.17 Lujiang Road, Hefei, 230001, China
9 Wenyuan Road, Nanjing, 210023, China
320 Yueyang Road, Yueyang, 200031, China
State Key Laboratory Of Bioreactor Engineering, Shanghai, 200237, China
299 Qingyang Road, Wuxi, 214000, China
No.8 East Street, Fengtai, 100071, China
No.164 Lanxi Road, Shanghai, 200062, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Multicenter, Randomized, Open-label, 2-arm, Phase II Study With a Safety lead-in Phase Evaluating the Combination of Encorafenib and Cetuximab Versus Irinotecan/Cetuximab or Infusional 5-fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab in Chinese Patients With BRAF V600E Mutant Metastatic Colorectal Cancer.
A Multicenter, Randomized, Open-label, 2-arm, Phase II Study With a Safety lead-in Phase Evaluating the Combination of Encorafenib and Cetuximab Versus Irinotecan/Cetuximab or Infusional 5-fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab in Chinese Patients With BRAF V600E Mutant Metastatic Colorectal Cancer.
Enrollment Status: Completed
Publish Date: April 15, 2025
Intervention Type: Drug
Study Phase: Phase 2

414 Total Publications

Efficient Production of the Recombinant Human Lactoferrin in an Engineered Trichoderma reesei.
Efficient Production of the Recombinant Human Lactoferrin in an Engineered Trichoderma reesei.
Journal: Journal of agricultural and food chemistry
Published: December 13, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Shen's expertise for a condition
ConditionClose
      View All 9 Advanced Conditions
      View All 68 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile